Virios Therapeutics, Inc. (VIRI)
NASDAQ: VIRI · IEX Real-Time Price · USD
0.456
+0.031 (7.20%)
At close: Apr 25, 2024, 4:00 PM
0.452
-0.004 (-0.90%)
After-hours: Apr 25, 2024, 6:40 PM EDT
Virios Therapeutics Market Cap
Virios Therapeutics has a market cap or net worth of $8.78 million as of April 25, 2024. Its market cap has decreased by -30.34% in one year.
Market Cap
8.78M
Enterprise Value
5.46M
1-Year Change
-30.34%
Ranking
Category
Stock Price
$0.46
Market Cap Chart
Since the IPO on December 17, 2020, Virios Therapeutics's market cap has decreased from $78.32M to $8.78M, a decrease of -88.79%. That is a compound annual growth rate of -47.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 8.80M | 7.32% |
Apr 24, 2024 | 8.20M | -1.20% |
Apr 23, 2024 | 8.30M | 1.22% |
Apr 22, 2024 | 8.20M | -2.38% |
Apr 19, 2024 | 8.40M | -3.45% |
Apr 18, 2024 | 8.70M | - |
Apr 17, 2024 | 8.70M | - |
Apr 16, 2024 | 8.70M | -4.40% |
Apr 15, 2024 | 9.10M | -8.08% |
Apr 12, 2024 | 9.90M | 7.61% |
Apr 11, 2024 | 9.20M | 2.22% |
Apr 10, 2024 | 9.00M | 1.12% |
Apr 9, 2024 | 8.90M | 2.30% |
Apr 8, 2024 | 8.70M | -1.14% |
Apr 5, 2024 | 8.80M | -5.38% |
Apr 4, 2024 | 9.30M | -2.11% |
Apr 3, 2024 | 9.50M | -8.65% |
Apr 2, 2024 | 10.40M | -7.14% |
Apr 1, 2024 | 11.20M | 21.74% |
Mar 28, 2024 | 9.20M | -1.08% |
Mar 27, 2024 | 9.30M | 12.05% |
Mar 26, 2024 | 8.30M | -8.79% |
Mar 25, 2024 | 9.10M | 3.41% |
Mar 22, 2024 | 8.80M | 37.50% |
Mar 21, 2024 | 6.40M | -5.88% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NeuroMetrix | 8.60M |
BioRestorative Therapies | 8.60M |
Biofrontera | 8.45M |
ASLAN Pharmaceuticals | 8.27M |
Longeveron | 8.25M |
Precipio | 8.05M |
NuCana | 8.04M |
Akari Therapeutics, | 7.87M |